Document is current
Any future updates will be listed below
-
Authors
Xu, Bo
Han, Hang
Hao, Yao
Shang, Yitong
Deng, Yu
Zhang, Zhen
Ding, Liyang
Pei, Xiuying
Fu, Xufeng
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of Ningxia (2024AAC05067)
the National Natural Science Foundation of China (82560300)
- License Information
-
More Information
Article History
Received: 18 September 2025
Accepted: 2 January 2026
First Online: 8 January 2026
Declarations
:
: All human samples and animal studies were approved by the Medical and Ethics Committee of Ningxia Medical University (NXMU-2024-N016). The project “Study on the mechanism of umbilical cord mSC-derived exosomes alleviates chemotherapy-induced ovarian damage by attenuating ferritinophagy in ovarian granulosa cells; NXMU-2024-N016” was approved by the Ethics Committee of Ningxia Medical University (April 16, 2024). The KGN cells were purchased from Wuhan Procell Life Technology Co., LTD. This company has The KGN cells were purchased from Wuhan Procell Life Technology Co., Ltd., which confirmed that there was initial ethical approval for the collection of human cells, and that the donors had signed informed consent ( ). The work has been reported in line with the ARRIVE 2.0 guidelines.
: The authors declare no competing interests.
